Keine Story von CartiHeal mehr verpassen.


  • 30.03.2022 – 13:01

    FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects

    Kfar Saba, Israel (ots/PRNewswire) - Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint CartiHeal Ltd, developer of implants for the treatment of cartilage and ...